DeMelle OncoPharma Licenses Clinical-Stage Technology from Moffitt Cancer Center for New Targeted Pancreatic Cancer Treatment
Company developing DM3001 as first-in-class treatment against novel cancer target TARPON SPRINGS, FL / ACCESSWIRE / March 4, 2020 /...
MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi